|
MSL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.817600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.419580E-01 |
| Normal-vs-Stage2 |
1.441400E-03 |
| Normal-vs-Stage3 |
3.577900E-02 |
| Normal-vs-Stage4 |
2.181500E-02 |
| Stage1-vs-Stage2 |
1.318440E-02 |
| Stage1-vs-Stage3 |
2.622000E-01 |
| Stage1-vs-Stage4 |
1.724830E-01 |
| Stage2-vs-Stage3 |
1.263400E-01 |
| Stage2-vs-Stage4 |
3.142800E-01 |
| Stage3-vs-Stage4 |
6.405200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.355600E-02 |
| Normal-vs-AfricanAmerican |
4.083700E-02 |
| Normal-vs-Asian |
8.674800E-01 |
| Caucasian-vs-AfricanAmerican |
2.840800E-01 |
| Caucasian-vs-Asian |
1.198380E-01 |
| AfricanAmerican-vs-Asian |
3.270200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.220200E-02 |
| Normal-vs-Female |
2.274300E-02 |
| Male-vs-Female |
7.734000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.100600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.868200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.664400E-03 |
| Normal-vs-Age(81-100Yrs) |
8.368000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.450800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.782100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.050400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.284000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.526400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.601400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.621010E-01 |
| Classical-VS-Follicular |
2.49156251186378E-12 |
| Classical-VS-Other |
1.133800E-01 |
| Classical-VS-Normal |
4.821600E-01 |
| Tall-VS-Follicular |
5.582400E-03 |
| Tall-VS-Other |
4.653200E-01 |
| Tall-VS-Normal |
1.282450E-01 |
| Follicular-VS-Other |
4.664400E-01 |
| Follicular-VS-Normal |
1.78590000010637E-07 |
| Other-VS-Normal |
1.090640E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.724700E-03 |
| Normal-vs-N1 |
3.154000E-02 |
| N0-vs-N1 |
8.681000E-01 |
|
|
